FIELD: medicine; chemistry.
SUBSTANCE: present invention relates to a compound of formula usable in medicine 
or pharmaceutically acceptable salts thereof, wherein
(Amino acid)
EFFECT: novel compounds and pharmaceutical compositions effective for treating pathologies associated with a deficiency of pantothenate kinase, 4'-phosphopantothenate or coenzyme A, including neurological diseases are proposed.
20 cl, 17 ex, 3 tbl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| NEUROACTIVE COMPOUNDS AND THEIR APPLICATION METHODS | 2015 |
|
RU2764702C2 |
| PYRROLO-PYRROLE COMPOSITIONS AS ACTIVATORS OF PYRUVATE KINASE (PKR) | 2018 |
|
RU2736217C2 |
| METHODS OF TREATING CANCER | 2013 |
|
RU2677276C2 |
| SUBSTITUTED THIADIAZINONE DIOXIDE, METHOD OF ITS OBTAINING, ITS HERBICIDAL COMPOSITION AND ITS USE | 2020 |
|
RU2812578C1 |
| LOW-MOLECULAR INHIBITORS OF N-TERMINUS ACTIVATION OF ANDROGEN RECEPTOR | 2009 |
|
RU2519948C2 |
| QUINOXALINE-CONTAINING COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS | 2008 |
|
RU2493160C2 |
| USE OF SUBSTITUTED OXADIAZOLES FOR CONTROLLING PHYTOPATHOGENIC FUNGI | 2015 |
|
RU2685949C2 |
| HUMAN EZH2 INHIBITORS AND METHODS FOR USE THEREOF | 2013 |
|
RU2704445C2 |
| BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS FOR USE THEREOF | 2015 |
|
RU2707280C2 |
| BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS FOR USE THEREOF | 2016 |
|
RU2712099C2 |
